GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1.66 Cr | ₹1.30 Cr | ₹1.02 Cr | ₹0.98 Cr | ₹0.86 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹1.66 Cr |
Mar2023 | ₹1.30 Cr |
Mar2022 | ₹1.02 Cr |
Mar2021 | ₹0.98 Cr |
Mar2020 | ₹0.86 Cr |
How is Deferred Tax Assets / Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.66 Cr | 28.00 | |
Mar2023 | ₹1.30 Cr | 26.95 | |
Mar2022 | ₹1.02 Cr | 4.60 | |
Mar2021 | ₹0.98 Cr | 13.31 | |
Mar2020 | ₹0.86 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹3,720.2 Cr | -2.4% | 2.6% | 10.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,788.0 Cr | -0.6% | 0.8% | 10.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,283.0 Cr | 3.1% | 3.8% | 49.2% | Stock Analytics | |
CIPLA | ₹121,853.0 Cr | 0.4% | 2.5% | 1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,914.0 Cr | -0.2% | 6.4% | 20.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,932.0 Cr | -0.6% | 3.3% | 0.1% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -2.4% |
2.6% |
10.5% |
SENSEX | -0.6% |
3.1% |
5.3% |
You may also like the below Video Courses